1. Home
  2. SBUX vs SNY Comparison

SBUX vs SNY Comparison

Compare SBUX & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Starbucks Corporation

SBUX

Starbucks Corporation

HOLD

Current Price

$96.03

Market Cap

103.0B

ML Signal

HOLD

Logo Sanofi ADS

SNY

Sanofi ADS

HOLD

Current Price

$46.30

Market Cap

107.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SBUX
SNY
Founded
1971
1994
Country
United States
France
Employees
N/A
74846
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
103.0B
107.3B
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
SBUX
SNY
Price
$96.03
$46.30
Analyst Decision
Buy
Buy
Analyst Count
27
5
Target Price
$100.65
$58.00
AVG Volume (30 Days)
7.1M
2.9M
Earning Date
04-28-2026
04-23-2026
Dividend Yield
2.57%
3.42%
EPS Growth
N/A
N/A
EPS
0.26
N/A
Revenue
$37,184,400,000.00
N/A
Revenue This Year
$5.21
$3.86
Revenue Next Year
$5.23
$5.64
P/E Ratio
$371.35
$6.14
Revenue Growth
2.79
N/A
52 Week Low
$75.50
$43.32
52 Week High
$104.82
$55.73

Technical Indicators

Market Signals
Indicator
SBUX
SNY
Relative Strength Index (RSI) 54.32 49.35
Support Level $93.55 $45.20
Resistance Level $99.41 $48.88
Average True Range (ATR) 2.33 0.70
MACD 0.72 0.05
Stochastic Oscillator 83.28 48.18

Price Performance

Historical Comparison
SBUX
SNY

About SBUX Starbucks Corporation

Starbucks stands out as the world's biggest and most recognizable coffee brand, powered by ultracustomizable beverages in-store and a sweeping footprint of nearly 41,000 cafes in over 80 countries. About 52% are company-operated, with the balance run by licensees. The company operates roasteries and sells across its North America (74% of revenue as of the end of fiscal 2025), international (21%), and channel development (5%) segments. The brand collects revenue from company-operated stores, licensee royalties, equipment and product sales, retail ready-to-drink beverages, and packaged coffee.

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Share on Social Networks: